Japanese Pharmaceuticals & Biotech Big Green Snowflakes

Tsumura

Market Cap: JP¥327.0b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Zeria Pharmaceutical

Market Cap: JP¥99.8b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Takeda Pharmaceutical

Market Cap: JP¥6.4t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥5.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Ono Pharmaceutical

Market Cap: JP¥805.8b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Nippon Shinyaku

Market Cap: JP¥240.6b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

PeptiDream

Market Cap: JP¥233.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Daito PharmaceuticalLtd

Market Cap: JP¥31.0b

Manufactures and sells pharmaceutical products worldwide.

Chugai Pharmaceutical

Market Cap: JP¥11.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥326.1b

Manufactures and sells pharmaceuticals in Japan.

Towa Pharmaceutical

Market Cap: JP¥122.7b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Fuji Pharma

Market Cap: JP¥32.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Eisai

Market Cap: JP¥1.1t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Solasia Pharma K.K

Market Cap: JP¥7.2b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

CellSource

Market Cap: JP¥12.3b

Engages in the regenerative medicine-related businesses in Japan.

Santen Pharmaceutical

Market Cap: JP¥469.2b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Kaken Pharmaceutical

Market Cap: JP¥158.2b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥64.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Sawai Group Holdings

Market Cap: JP¥222.2b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Kissei Pharmaceutical

Market Cap: JP¥153.2b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥51.4b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Takara Bio

Market Cap: JP¥93.8b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Linical

Market Cap: JP¥6.5b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

JCR Pharmaceuticals

Market Cap: JP¥51.0b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Astellas Pharma

Market Cap: JP¥2.4t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Mochida Pharmaceutical

Market Cap: JP¥105.0b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

WDB coco

Market Cap: JP¥7.8b

Provides contract services to pharmaceutical companies in Japan.

Seikagaku

Market Cap: JP¥36.4b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Astena Holdings

Market Cap: JP¥18.5b

Manufactures and sells medicine-related products in Japan.

Japan Tissue Engineering

Market Cap: JP¥18.2b

Engages in the regenerative medicine business in Japan.

Pharma Foods International

Market Cap: JP¥24.2b

Engages in the development and sale of functional food ingredients in Japan.

Human Metabolome Technologies

Market Cap: JP¥4.0b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Immuno-Biological Laboratories

Market Cap: JP¥4.1b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.